LAS VEGAS, April 13, 2017 -- On April 10th 2017, THC Therapeutics (OTC:THCT) announced a pending acquisition on a profitable health and wellness float spa. In that press release we stated that we are in discussions with several physicians to facilitate our medical program. As promised, we have hired the first member of our medical board, Dr. John Pierce. Dr. Pierce is the Medical Director and President of Ageless Forever, an anti-aging & longevity clinic based in Las Vegas, NV.
Ageless Forever - http://www.agelessforever.net/
Dr. Pierce has been practicing medicine for almost 15 years, he has tremendous experience in the wellness industry ranging from nutritional supplements, herbs, Vitamin IV, anti-aging and is a foremost expert in hormone replacement therapy. Unlike many doctors, Pierce looks at medicine from a holistic standpoint. He understands that pharmaceuticals have their place in medicine, but agrees with THC Therapeutics that many issues can be solved with proper diet, nutrition, exercise and specialized therapies.
THC Therapeutics, with our new Medical Director, is currently in discussions with additional physicians to establish our medical board. The Medical Board is being assembled to focus on those suffering from depression, anxiety, chronic pain, substance abuse, addiction and many other ailments. There have been studies which show both cannabis and flotation therapy’s effectiveness in relieving many of the previously mentioned symptoms.
Dr. Pierce’s comments: “I am proud to be a part of THC Therapeutics. I look forward to helping expand the company's profile with nutritional healing through IV therapies and more. My passion is an integrative approach to health and wellness focused on more holistic therapies. I believe in the medical applications and benefits of cannabis. I look forward to helping THC Therapeutics become a leader and front runner in the health and wellness industry.”
Brandon Romanek, the Founder and CEO states: “I personally couldn’t be more thrilled that our new Medical Director has such a knowledgeable understanding of how to practice medicine. The hiring of Dr. Pierce is a very important first step in showing we are serious about helping people enhance their quality of life. As stated, we are in the process of completing our first small acquisition and we are generating some momentum, but I am determined to bring rapid growth to THC Therapeutics -- the best way to do that is with MAJOR acquisitions, mergers and partnerships. Rest assured, I will only make deals that benefit our company and shareholders. Even as a new publicly traded company, we are making tremendous progress on our goals. For such a respected and prestigious doctor to place his reputation behind our company shows tremendous confidence in our vision, leadership and direction. We are beginning to assemble the best talent available and with the opportunities in this young industry, I believe we can become one of the elite companies in the Cannabis space. I want to make this VERY CLEAR, as CEO of THCT, ACTIONS speak much louder than words. I’m putting my all into creating a publicly traded Health and Healing company like no other.
About THC Therapeutics:
THC Therapeutics is a forward-thinking publicly traded health and healing company in the cannabis industry that has "Better Health through the Science of Nature" as their mission statement. The company is dedicated to innovating new methods and refining current industry standards in the cannabis market. THC Therapeutics' plans for future growth include cultivation, dispensing, extractions, edibles, personal wellness centers and flotation therapy. For more information, visit THCTherapeutics.com.
Forward-Looking Statements Disclosure:
This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," "plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.
Follow Brandon Romanek on Twitter:
Twitter @BrandonRomanek
Follow THC Therapeutics on Facebook and Twitter:
Twitter @THCTherapeutics
Facebook @THCTherapies
Media Contact: [email protected]


Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
First Western Ship Transits Strait of Hormuz Since Iran War Began
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Apple Turns 50: From Garage Startup to AI Crossroads
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 



